Emerging Tests: New Genetic Tests May Be Better than PSA Screening in Assessing Prostate Cancer Risk

The U.S. Preventive Services Task Force (USPTF) recommends that men age 55 to 65 consider prostate cancer screening based on their specific circumstances. The reason that the USPTF does not directly … [Read more...]


PSA Testing Patterns Vary By Medical Specialty

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Prostate specific antigen (PSA) testing varies significantly by physician specialty, according to a research letter published … [Read more...]